6 research outputs found
ΠΡΡΡΡΠΉ Ρ ΠΎΠ»Π΅ΡΠΈΡΡΠΈΡ ΠΊΠ°ΠΊ ΠΏΠ΅ΡΠ²ΠΎΠ΅ ΠΏΡΠΎΡΠ²Π»Π΅Π½ΠΈΠ΅ ΠΏΠ΅ΡΠ²ΠΈΡΠ½ΠΎΠ³ΠΎ ΠΏΠ»ΠΎΡΠΊΠΎΠΊΠ»Π΅ΡΠΎΡΠ½ΠΎΠ³ΠΎ ΡΠ°ΠΊΠ° ΠΆΠ΅Π»ΡΠ½ΠΎΠ³ΠΎ ΠΏΡΠ·ΡΡΡ: ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΈΠΉ ΡΠ»ΡΡΠ°ΠΉ
Background. SCC of the gallbladder is characterized by more rapid and invasive growth with infiltration of the adjacent organs and less spread to the lymph nodes compared to adenocarcinoma of the gallbladder. It is a rare neoplasm that accounts for 1.4β12.7 % of gallbladder tumors. SCC of the gallbladder has a poor prognosis. symptoms usually appear later when the disease has progressed and the malignancy has reached advanced stages. therefore, usually, the patients expire soon following the diagnosis. the etiology of the SCC of the gallbladder is complex and is mostly associated with gallstones. Case description. We report a case of a 56-year-old man that had been suffering from colicky abdominal pain in the right upper quadrant for about two weeks before his admission. He did not have nausea, vomiting, shortness of breath, fever, lack of appetite, or weight loss. after evaluation, a diagnosis of acute cholecystitis was established and antibiotic therapy was initiated. However, he did not respond to medical therapy and underwent surgery. A tumor mass was detected during surgery. therefore, cholecystectomy and extended right hepatectomy were performed. The pathological evaluation of the biopsy specimen revealed squamous cell carcinoma. consequently, he underwent radiotherapy and chemotherapy and was followed up for two years. He acquired complete tumor remission. Conclusion. The present case highlights the requirement of considering further investigation on the histogenesis of SCC of the gallbladder.ΠΠΊΡΡΠ°Π»ΡΠ½ΠΎΡΡΡ. ΠΠΎ ΡΡΠ°Π²Π½Π΅Π½ΠΈΡ Ρ Π°Π΄Π΅Π½ΠΎΠΊΠ°ΡΡΠΈΠ½ΠΎΠΌΠΎΠΉ ΠΏΠ»ΠΎΡΠΊΠΎΠΊΠ»Π΅ΡΠΎΡΠ½ΡΠΉ ΡΠ°ΠΊ ΠΆΠ΅Π»ΡΠ½ΠΎΠ³ΠΎ ΠΏΡΠ·ΡΡΡ (ΠΠ ΠΠ) Ρ
Π°ΡΠ°ΠΊΡΠ΅ΡΠΈΠ·ΡΠ΅ΡΡΡ Π±ΠΎΠ»Π΅Π΅ Π±ΡΡΡΡΡΠΌ ΠΈ ΠΈΠ½Π²Π°Π·ΠΈΠ²Π½ΡΠΌ ΡΠΎΡΡΠΎΠΌ Ρ ΠΈΠ½ΡΠΈΠ»ΡΡΡΠ°ΡΠΈΠ΅ΠΉ ΡΠΎΡΠ΅Π΄Π½ΠΈΡ
ΠΎΡΠ³Π°Π½ΠΎΠ² ΠΈ Π±ΠΎΠ»Π΅Π΅ ΡΠ΅Π΄ΠΊΠΈΠΌ ΠΏΠΎΡΠ°ΠΆΠ΅Π½ΠΈΠ΅ΠΌ Π»ΠΈΠΌΡΠ°ΡΠΈΡΠ΅ΡΠΊΠΈΡ
ΡΠ·Π»ΠΎΠ². ΠΡΠΎ ΡΠ΅Π΄ΠΊΠΎΠ΅ Π½ΠΎΠ²ΠΎΠΎΠ±ΡΠ°Π·ΠΎΠ²Π°Π½ΠΈΠ΅, Π½Π° Π΄ΠΎΠ»Ρ ΠΊΠΎΡΠΎΡΠΎΠ³ΠΎ ΠΏΡΠΈΡ
ΠΎΠ΄ΠΈΡΡΡ 1,4β12,7 % ΠΎΠΏΡΡ
ΠΎΠ»Π΅ΠΉ ΠΆΠ΅Π»ΡΠ½ΠΎΠ³ΠΎ ΠΏΡΠ·ΡΡΡ. ΠΠ ΠΠ ΠΈΠΌΠ΅Π΅Ρ ΠΏΠ»ΠΎΡ
ΠΎΠΉ ΠΏΡΠΎΠ³Π½ΠΎΠ·. Π‘ΠΈΠΌΠΏΡΠΎΠΌΡ ΠΎΠ±ΡΡΠ½ΠΎ ΠΏΠΎΡΠ²Π»ΡΡΡΡΡ Π½Π° ΠΏΠΎΠ·Π΄Π½ΠΈΡ
ΡΡΠ°Π΄ΠΈΡΡ
Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΡ, Π² ΡΠ²ΡΠ·ΠΈ Π² ΡΠ΅ΠΌ ΠΏΠ°ΡΠΈΠ΅Π½ΡΡ ΡΠ°ΡΡΠΎ ΡΠΌΠΈΡΠ°ΡΡ Π²ΡΠΊΠΎΡΠ΅ ΠΏΠΎΡΠ»Π΅ ΠΏΠΎΡΡΠ°Π½ΠΎΠ²ΠΊΠΈ Π΄ΠΈΠ°Π³Π½ΠΎΠ·Π°. ΠΡΠΈΠΎΠ»ΠΎΠ³ΠΈΡ ΠΠ ΠΠ ΡΠ»ΠΎΠΆΠ½Π°Ρ ΠΈ Π² ΠΎΡΠ½ΠΎΠ²Π½ΠΎΠΌ ΡΠ²ΡΠ·Π°Π½Π° Ρ Π½Π°Π»ΠΈΡΠΈΠ΅ΠΌ ΠΊΠΎΠ½ΠΊΡΠ΅ΠΌΠ΅Π½ΡΠΎΠ² Π² ΠΆΠ΅Π»ΡΠ½ΠΎΠΌ ΠΏΡΠ·ΡΡΠ΅. ΠΠΏΠΈΡΠ°Π½ΠΈΠ΅ ΡΠ»ΡΡΠ°Ρ. ΠΠ°ΡΠΈΠ΅Π½Ρ, 56 Π»Π΅Ρ, ΠΏΠΎΡΡΡΠΏΠΈΠ» Π² ΡΡΠ°ΡΠΈΠΎΠ½Π°Ρ Ρ ΠΆΠ°Π»ΠΎΠ±Π°ΠΌΠΈ Π½Π° ΠΊΠΎΠ»ΠΈΠΊΠΎΠΎΠ±ΡΠ°Π·Π½ΡΠ΅ Π±ΠΎΠ»ΠΈ Π² ΠΏΡΠ°Π²ΠΎΠΌ ΠΏΠΎΠ΄ΡΠ΅Π±Π΅ΡΡΠ΅, ΠΊΠΎΡΠΎΡΡΠ΅ Π²ΠΎΠ·Π½ΠΈΠΊΠ»ΠΈ ΠΏΡΠΈΠΌΠ΅ΡΠ½ΠΎ Π·Π° 2 Π½Π΅Π΄ Π΄ΠΎ Π³ΠΎΡΠΏΠΈΡΠ°Π»ΠΈΠ·Π°ΡΠΈΠΈ; ΡΠΎΡΠ½ΠΎΡΡ, ΡΠ²ΠΎΡΡ, ΠΎΠ΄ΡΡΠΊΠΈ, Π»ΠΈΡ
ΠΎΡΠ°Π΄ΠΊΠΈ, ΠΎΡΡΡΡΡΡΠ²ΠΈΡ Π°ΠΏΠΏΠ΅ΡΠΈΡΠ° ΠΈΠ»ΠΈ ΠΏΠΎΡΠ΅ΡΠΈ Π²Π΅ΡΠ° Π½Π΅ ΠΎΡΠΌΠ΅ΡΠ°Π». ΠΠΎΡΠ»Π΅ ΠΎΠ±ΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ ΡΡΡΠ°Π½ΠΎΠ²Π»Π΅Π½ Π΄ΠΈΠ°Π³Π½ΠΎΠ· ΠΎΡΡΡΠΎΠ³ΠΎ Ρ
ΠΎΠ»Π΅ΡΠΈΡΡΠΈΡΠ° ΠΈ Π½Π°ΡΠ°ΡΠ° Π°Π½ΡΠΈΠ±Π°ΠΊΡΠ΅ΡΠΈΠ°Π»ΡΠ½Π°Ρ ΡΠ΅ΡΠ°ΠΏΠΈΡ, ΠΊΠΎΡΠΎΡΠ°Ρ Π½Π΅ Π΄Π°Π»Π° ΠΏΠΎΠ»ΠΎΠΆΠΈΡΠ΅Π»ΡΠ½ΡΡ
ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΠΎΠ², ΠΈ ΠΏΠ°ΡΠΈΠ΅Π½ΡΡ Π±ΡΠ»Π° Π²ΡΠΏΠΎΠ»Π½Π΅Π½Π° ΠΎΠΏΠ΅ΡΠ°ΡΠΈΡ, ΠΏΡΠΈ ΡΠ΅Π²ΠΈΠ·ΠΈΠΈ ΠΎΠ±Π½Π°ΡΡΠΆΠ΅Π½Π° ΠΎΠΏΡΡ
ΠΎΠ»Ρ ΠΆΠ΅Π»ΡΠ½ΠΎΠ³ΠΎ ΠΏΡΠ·ΡΡΡ, ΡΡΠΎ ΡΠ²ΠΈΠ»ΠΎΡΡ ΠΏΠΎΠΊΠ°Π·Π°Π½ΠΈΠ΅ΠΌ Π΄Π»Ρ Ρ
ΠΎΠ»Π΅ΡΠΈΡΡΡΠΊΡΠΎΠΌΠΈΠΈ ΠΈ ΡΠ°ΡΡΠΈΡΠ΅Π½Π½ΠΎΠΉ ΠΏΡΠ°Π²ΠΎΡΡΠΎΡΠΎΠ½Π½Π΅ΠΉ Π³Π΅ΠΌΠΈΠ³Π΅ΠΏΠ°ΡΡΠΊΡΠΎΠΌΠΈΠΈ. ΠΡΠΈ Π³ΠΈΡΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠΌ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠΈ Π±ΠΈΠΎΠΏΡΠΈΠΉΠ½ΠΎΠ³ΠΎ ΠΌΠ°ΡΠ΅ΡΠΈΠ°Π»Π° Π²ΡΡΠ²Π»Π΅Π½ ΠΏΠ»ΠΎΡΠΊΠΎΠΊΠ»Π΅ΡΠΎΡΠ½ΡΠΉ ΡΠ°ΠΊ. ΠΠΎΡΠ»Π΅ ΠΎΠΏΠ΅ΡΠ°ΡΠΈΠΈ Π½Π°Π·Π½Π°ΡΠ΅Π½Π° Π»ΡΡΠ΅Π²Π°Ρ ΡΠ΅ΡΠ°ΠΏΠΈΡ ΠΈ Ρ
ΠΈΠΌΠΈΠΎΡΠ΅ΡΠ°ΠΏΠΈΡ. ΠΡΠΈ Π΄ΠΈΠ½Π°ΠΌΠΈΡΠ΅ΡΠΊΠΎΠΌ Π½Π°Π±Π»ΡΠ΄Π΅Π½ΠΈΠΈ Π² ΡΠ΅ΡΠ΅Π½ΠΈΠ΅ 2 Π»Π΅Ρ ΠΎΡΠΌΠ΅ΡΠ°Π΅ΡΡΡ ΠΏΠΎΠ»Π½Π°Ρ ΡΠ΅ΠΌΠΈΡΡΠΈΡ ΠΎΠΏΡΡ
ΠΎΠ»ΠΈ. ΠΠ°ΠΊΠ»ΡΡΠ΅Π½ΠΈΠ΅. ΠΡΠ΅Π΄ΡΡΠ°Π²Π»Π΅Π½Π½ΡΠΉ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΈΠΉ ΡΠ»ΡΡΠ°ΠΉ ΠΏΠΎΠ΄ΡΠ΅ΡΠΊΠΈΠ²Π°Π΅Ρ Π½Π΅ΠΎΠ±Ρ
ΠΎΠ΄ΠΈΠΌΠΎΡΡΡ Π΄Π°Π»ΡΠ½Π΅ΠΉΡΠ΅Π³ΠΎ ΠΈΠ·ΡΡΠ΅Π½ΠΈΡ Π³ΠΈΡΡΠΎΠ³Π΅Π½Π΅Π·Π° ΠΏΠ»ΠΎΡΠΊΠΎΠΊΠ»Π΅ΡΠΎΡΠ½ΠΎΠ³ΠΎ ΡΠ°ΠΊΠ° ΠΆΠ΅Π»ΡΠ½ΠΎΠ³ΠΎ ΠΏΡΠ·ΡΡΡ
Impact of cancers on the kidney function and structure; An ignored entity
Important declines have been observed in urological cancer-related mortality in recent decades, mainly due to improvements in treatments of prostate cancer, less exposure to tobacco smoking as well as occupational carcinogens of kidney and bladder. However, because of global population ageing, age-related urinary tract cancers are expected to increase in the near future despite improved primary prevention, early detection and more efficient treatment. In this article, renal cell carcinoma (RCC), kidney transplantation, cancer and acute kidney injury (AKI), lung cancer and chronic kidney disease (CKD), breast cancer, prostate cancer, cervix cancer and brain cancer and their associations with kidney function and structure have been discussed. In conclusion, kidney and cancers have interaction with each other. Kidney carcinoma can be metastasizing to other organs as well as other cancer to kidney. Therefore, it is recommended to consider the potential effect of kidney functions and interaction with other cancers in each malignancy. ΓΒ© 2018 The Author(s)
Impact of cancers on the kidney function and structure; An ignored entity
Important declines have been observed in urological cancer-related mortality in recent decades, mainly due to improvements in treatments of prostate cancer, less exposure to tobacco smoking as well as occupational carcinogens of kidney and bladder. However, because of global population ageing, age-related urinary tract cancers are expected to increase in the near future despite improved primary prevention, early detection and more efficient treatment. In this article, renal cell carcinoma (RCC), kidney transplantation, cancer and acute kidney injury (AKI), lung cancer and chronic kidney disease (CKD), breast cancer, prostate cancer, cervix cancer and brain cancer and their associations with kidney function and structure have been discussed. In conclusion, kidney and cancers have interaction with each other. Kidney carcinoma can be metastasizing to other organs as well as other cancer to kidney. Therefore, it is recommended to consider the potential effect of kidney functions and interaction with other cancers in each malignancy
Prevalence and antibiotic resistance pattern of extended spectrum beta lactamase producing Escherichia coli isolated from urinary tract infection
Introduction: Urinary tract infection (UTI) due to extended spectrum beta-lactamase (ESBL)-producing bacteria including Escherichia coli has become widespread. Studies have shown a trend toward higher mortality, longer hospitalization, greater hospital expenses and reduced rates of clinical and microbiologic response in ESBL UTI. Objectives: The aim of this study is to determinate the prevalence and antibiotic resistance pattern of ESBL producing E. coli isolated from UTI. Patients and Methods: This cross-sectional study was conducted on 3126 samples. Urine specimens were cultured on Eosin Methylene Blue (EBM) and blood agar. The disk diffusion standard method (Kirby Bauer) was used to test the susceptibility of the drug on Muller- Hinton agar plates and results were reviewed based on Clinical and Laboratory Standards Institute (CLSI) criteria. The reviewing of ESBL-producing uropathogens was carried out using Combined Disk Test (CDT) by using cefotaxime (CTX; 30 ΓΒΌg) and cefotaximeclavulanic acid (CTX; 30 ΓΒΌg /CA:10 ΓΒΌg) disks and CLSI protocol. Results: Out of 291 E. coli isolates, 108 (37.11) are ESBL-producer and 183 (62.89) are non-ESBL-producer. Among ESBL-producing E. coli, the highest antibiotic resistance was observed with cefotaxime (100), amoxicillin (97.22) and piperacillin (96.3) and the highest antibiotic sensitivity was observed with meropenem (93.5), nitrofurantoin (81.48) and gentamicin (55.56). Conclusion: We recommended that cephalosporins, penicillins and cotrimoxazole are not suggested in the treatment of ESBL-producing E. coli. On the other hand, carbapenems as a first line and aminoglycosides as the next step in the treatment of ESBL-producing E. coli are recommended. ΓΒ© 2019 The Author(s)
Evaluation of possible relationship between COL4A4 gene polymorphisms and risk of keratoconus
Purpose: Keratoconus (KC) is a genetically heterogeneous corneal dystrophy with unknown etiology that causes loss of visual acuity. Evidence has shown that corneas from patients with KC contain reduced amounts of total collagen proteins, and collagen type IV has been suggested as a candidate gene in KC pathogenesis. This study aimed to evaluate the possible associations between collagen type IV alpha-4 chain (COL4A4) polymorphisms (rs2229813 G/A, M1327V and rs2228555 A/G, V1516V) and susceptibility to KC. Methods: A total of 262 Iranian subjects including 112 patients with KC and 150 healthy individuals as controls were recruited in this case-control study. Diagnosis was based on clinical examination, electronic refractometry, and keratometry. Genotyping for the COL4A4 rs2229813 and rs2228555 variants was executed using allele-specific polymerase chain reaction and Tetra-ARMS polymerase chain reaction, respectively. Results: A significant difference was found between the 2 groups regarding allelic and genotyping distribution of COL4A4 polymorphism at position rs2229813 G>A. The COL4A4 rs2229813 AA and GA+AA genotypes were risk factors for developing KC (odds ratio OR 2.1, P 0.036 and OR 1.7, P 0.042, for the AA and GA+AA genotypes, respectively). The COL4A4 rs2229813 A allele was also associated with an increased risk for KC (OR 1.5, 95% confidence intervals: 1.1-2.2, P 0.018). However, in our study, we found no association between COL4A4 rs2228555 polymorphism and the risk of KC. Conclusions: We suggest that the COL4A4 rs2229813 AA and GA+AA genotypes as well as the A allele play roles as risk factors for developing KC in our population. Copyright ΓΒ© 2015 Wolters Kluwer Health, Inc. All rights reserved